Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study
Francesca Ferrua(Vita-Salute San Raffaele University), Peter Mustillo(Nationwide Children's Hospital), Krzysztof Kałwak(Poznan University of Medical Sciences), Kathleen E. Sullivan(University of Pennsylvania), Alexandra Laberko(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), Bénédicte Neven(Université Paris-Panthéon-Assas), Marina Cavazzana(Université Rennes 2), Aydan İkincioğulları(Ankara University), Manfred Hoenig, Fanny Fouyssac(Hôpital Necker-Enfants Malades), Hamoud Al‐Mousa(King Faisal Specialist Hospital & Research Centre), Robbert G. M. Bredius(Leiden University Medical Center), Despina Moshous(Hôpital Necker-Enfants Malades), Elena Soncini(University of Brescia), Michael H. Albert(LMU Klinikum), Felipe Suárez(Hôpital Necker-Enfants Malades), Gergely Kriván(National Center for Epidemiology), Figen Doğu(Ankara University), Hasan Al‐Dhekri(King Faisal Specialist Hospital & Research Centre), Stefania Galimberti(University of Milano-Bicocca), Jolanta Goździk(Jagiellonian University), Isabelle Meyts(KU Leuven), Christopher C. Dvorak(University of California, San Francisco), Vincent Barlogis, Virginie Courteille, Wojciech Czogała(Uniwersytecki Szpital Dziecięcy), Caroline A. Lindemans(University Medical Center Utrecht), Andrzej Lange(Cells Therapy (Poland)), Carsten Heilmann(Copenhagen University Hospital), Arjan C. Lankester(Leiden University Medical Center), Rand Arnaout(King Faisal Specialist Hospital & Research Centre), Anders Fasth(University of Gothenburg), Mary Slatter(First Pavlov State Medical University of St. Petersburg), Renata Formánková(Charles University), Per Ljungman(Karolinska University Hospital), Victoria Bordon(Ghent University Hospital), Beata Wolska‐Kuśnierz(Children's Memorial Health Institute), Dmitry Balashov(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), Laura Alonso(Vall d'Hebron Hospital Universitari), Anna Shcherbina, Monica Bhatia(Columbia University), Yves Bertrand(Hôpital Debrousse), Catharina Schuetz(Warrington and Halton Teaching Hospitals NHS Foundation Trust), Jadranka Kelečić(University Hospital Centre Zagreb), Victor M. Aquino(The University of Texas Southwestern Medical Center), Stéphane Blanche(Délégation Paris 5), Fulvio Porta(Ospedale dei Bambini Vittore Buzzi), Bandar Al‐Saud(King Faisal Specialist Hospital & Research Centre), Joanne Smart, Claire Booth(Great Ormond Street Hospital)
Cited by 91
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k